Department of Surgical Oncology, Medical University of Lublin, Radziwiłłowska 13 St., 20-080, Lublin, Poland.
Department of Surgical Oncology, Medical University of Lublin, Radziwiłłowska 13 St., 20-080, Lublin, Poland.
Eur J Surg Oncol. 2022 Feb;48(2):356-361. doi: 10.1016/j.ejso.2021.08.005. Epub 2021 Aug 11.
Perioperative chemotherapy (POC) in advanced gastric cancer (GC) patients significantly increases the curative resection rate and overall survival (OS). Textbook outcome (TO) represents a composite of surgical quality metrics strongly associated with improved OS. However, the current definition of TO after resection for GC does not include POC. Herein we propose to supplement the current description of TO with an additional feature, POC compliance. The present study aimed to evaluate prognostic impact of thus defined textbook oncological outcome (TOO) among patients undergoing gastrectomy for advanced GC.
We collected data from a prospectively maintained database of all patients operated for GC between 2010 and 2020 in our institution. Patients with histologically confirmed and resectable advanced GC but without distant metastases, in whom multimodal treatment was planned by institutional MDT were included.
A total of 194 patients were analyzed. In the multivariate analysis, patients with TOO had a 50 % lower risk of death than patients without TOO (medians: NR vs 42 months; HR = 0.50, p = 0.0109). Patients treated with POC had a 43 % lower risk of death than patients treated with only preoperative chemotherapy (medians: 78 vs 33 months; HR = 0.57, p = 0.0450). Patients with a pathological response (PR) in the primary tumor had a 59 % lower risk of death than patients without PR (medians: NR vs 36 months; HR = 0.41, p = 0.0229). POC combined with TO surgery significantly decreased the risk of death in advanced GC patients (medians: NR vs 42 months; HR = 0.35, p = 0.0258).
Since TOO is associated with improved survival, it may serve as a multimodal treatment quality parameter in patients with advanced GC.
围手术期化疗(POC)可显著提高晚期胃癌(GC)患者的根治性切除率和总生存期(OS)。教科书结局(TO)代表了与 OS 改善密切相关的手术质量指标的综合。然而,目前 GC 切除术后 TO 的定义不包括 POC。在此,我们建议在当前的 TO 描述中增加一个额外的特征,即 POC 依从性。本研究旨在评估在接受晚期 GC 胃切除术的患者中,经定义的教科书肿瘤学结局(TOO)的预后影响。
我们从 2010 年至 2020 年在我院接受 GC 手术的所有患者的前瞻性数据库中收集数据。纳入了经组织学证实且可切除的晚期 GC 但无远处转移且计划由机构多学科团队进行多模式治疗的患者。
共分析了 194 例患者。在多变量分析中,TOO 患者的死亡风险比无 TOO 患者低 50%(中位数:NR 比 42 个月;HR=0.50,p=0.0109)。接受 POC 治疗的患者比仅接受术前化疗的患者死亡风险低 43%(中位数:78 比 33 个月;HR=0.57,p=0.0450)。原发肿瘤有病理反应(PR)的患者死亡风险比无 PR 的患者低 59%(中位数:NR 比 36 个月;HR=0.41,p=0.0229)。POC 联合 TO 手术可显著降低晚期 GC 患者的死亡风险(中位数:NR 比 42 个月;HR=0.35,p=0.0258)。
由于 TOO 与改善的生存相关,因此它可以作为晚期 GC 患者多模式治疗质量的参数。